“Skin Clearance and Itch Relief in Black or African American Patients With Moderate-to-Severe Atopic Dermatitis Treated With Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s615, https://doi.org/10.25251/9qs79351.